A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Endometrial Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Rambam Health Care Campus ( Site 2025), Haifa, Israel

    Study coordinator · +972544850251
  • Carmel Hospital ( Site 2023), Haifa, Israel

    Study coordinator · +972544817280
  • Shaare Zedek Medical Center ( Site 2020), Jerusalem, Israel

    Study coordinator · 02-6555424
  • Meir Medical Center. ( Site 2021), Kfar Saba, Israel

    Study coordinator · 97297471575
  • Sourasky Medical Center ( Site 2022), Tel Aviv, Israel

    Study coordinator · 97236973494
  • University of South Alabama, Mitchell Cancer Institute ( Site 6033), Mobile, Alabama, United States

    Study coordinator · 251-665-8000
  • Alaska Women's Cancer Care ( Site 6036), Anchorage, Alaska, United States

    Study coordinator · 907-562-4673
  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine, California, United States

    Study coordinator · 714-456-8000
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020), Orange, California, United States

    Study coordinator · 949-813-1517
  • John Muir Health Cancer Center ( Site 6028), Walnut Creek, California, United States

    Study coordinator · 925-674-2580
  • Yale University School of Medicine ( Site 6009), New Haven, Connecticut, United States

    Study coordinator · 203-737-4450
  • MedStar Washington Hospital Center ( Site 5005), Washington D.C., District of Columbia, United States

    Study coordinator · 202-877-7000
  • Florida Cancer Specialists - South ( Site 7003), Fort Myers, Florida, United States

    Study coordinator · 239-274-9930
  • UF Health Davis Cancer Pavilion and Shands Med Plaza ( Site 6026), Gainesville, Florida, United States

    Study coordinator · 352-273-7832
  • Mount Sinai Braman Comprehensive Cancer Center ( Site 6031), Miami Beach, Florida, United States

    Study coordinator · 305-674-2625
  • AdventHealth Orlando-AdventHealth Medical Group Gynecological Oncology ( Site 6002), Orlando, Florida, United States

    Study coordinator · 407-609-3462
  • Florida Cancer Specialists ( Site 7002), St. Petersburg, Florida, United States

    Study coordinator · 727-522-0558
  • Florida Cancer Specialists East ( Site 7001), West Palm Beach, Florida, United States

    Study coordinator · 561-366-4100
  • St. Joseph's/Candler Health System ( Site 6021), Savannah, Georgia, United States

    Study coordinator · 912-819-5704
  • University of Chicago Medical Center ( Site 5002), Chicago, Illinois, United States

    Study coordinator · 773-702-1220
  • Parkview Research Center ( Site 6008), Fort Wayne, Indiana, United States

    Study coordinator · 800-724-8326
  • Women's Cancer Care ( Site 6010), Covington, Louisiana, United States

    Study coordinator · 985-317-6005
  • TRIALS 365 ( Site 6005), Shreveport, Louisiana, United States

    Study coordinator · 318-408-1198
  • Maine Medical Center - Scarborough Campus ( Site 6042), Scarborough, Maine, United States

    Study coordinator · 207-396-7089
  • Tufts Medical Center ( Site 6052), Boston, Massachusetts, United States

    Study coordinator · 617-636-2616
  • Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis, Minnesota, United States

    Study coordinator · 817-837-8660
  • St. Dominic's Hospital ( Site 5004), Jackson, Mississippi, United States

    Study coordinator · 601-200-4970
  • Holy Name Medical Center ( Site 6011), Teaneck, New Jersey, United States

    Study coordinator · 201-227-6200
  • University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque, New Mexico, United States

    Study coordinator · 505-272-4946
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 6055), Mineola, New York, United States

    Study coordinator · 516-708-4821
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York, New York, United States

    Study coordinator · 212-731-6455
  • Memorial Sloan Kettering Cancer Center ( Site 6053), New York, New York, United States

    Study coordinator · 212-639-2000
  • Duke Cancer Institute ( Site 6049), Durham, North Carolina, United States

    Study coordinator · 919-684-3780
  • FirstHealth of the Carolinas ( Site 6037), Pinehurst, North Carolina, United States

    Study coordinator · 910-715-8684
  • Miami Valley Hospital South ( Site 6014), Centerville, Ohio, United States

    Study coordinator · 937-438-7800
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus, Ohio, United States

    Study coordinator · 614-293-9337
  • Kettering Health Main Campus-Kettering Health Cancer Center ( Site 5001), Kettering, Ohio, United States

    Study coordinator · 937-395-6017
  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6047), Tulsa, Oklahoma, United States

    Study coordinator · 918-505-3200
  • Oncology Associates of Oregon, P.C. ( Site 8005), Eugene, Oregon, United States

    Study coordinator · 541-736-3385
  • St. Luke's University Health Network ( Site 6041), Bethlehem, Pennsylvania, United States

    Study coordinator · 484-503-4673
  • Hospital of the University of Pennsylvania ( Site 5007), Philadelphia, Pennsylvania, United States

    Study coordinator · 215-662-2487
  • Hospital of the University of Pennsylvania ( Site 6023), Philadelphia, Pennsylvania, United States

  • AHN West Penn Hospital ( Site 6006), Pittsburgh, Pennsylvania, United States

    Study coordinator · 412-578-1116
  • Women & Infants Hospital ( Site 5003), Providence, Rhode Island, United States

    Study coordinator · 401-453-7520
  • Erlanger Medical Center ( Site 5009), Chattanooga, Tennessee, United States

    Study coordinator · 423-778-3902
  • Texas Oncology - DFW ( Site 8004), Fort Worth, Texas, United States

    Study coordinator · 817-413-1500
  • Houston Methodist Hospital ( Site 6057), Houston, Texas, United States

    Study coordinator · 713-441-6616
  • Texas Oncology-San Antonio Medical Center ( Site 8001), San Antonio, Texas, United States

    Study coordinator · 210-595-5300
  • Texas Oncology - Northeast Texas ( Site 8002), Tyler, Texas, United States

    Study coordinator · 903-579-9800
  • Texas Oncology - Gulf Coast ( Site 8006), Webster, Texas, United States

    Study coordinator · 281-332-7505
  • Inova Schar Cancer Institute ( Site 6003), Fairfax, Virginia, United States

    Study coordinator · 571-472-4724
  • VCU Health Adult Outpatient Pavillion ( Site 5000), Richmond, Virginia, United States

    Study coordinator · 804-628-4368
  • Instituto Alexander Fleming ( Site 0105), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · +5491166936669
  • Instituto de Investigaciones Clínicas Mar del Plata ( Site 0108), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +542234963223
  • Fundación Respirar ( Site 0101), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541147815331
  • Hospital Británico de Buenos Aires ( Site 0103), CABA, Argentina

    Study coordinator · +541143096400
  • Instituto San Marcos ( Site 0106), San Juan, Argentina

    Study coordinator · +542645836798
  • Blacktown Hospital ( Site 0201), Blacktown, New South Wales, Australia

    Study coordinator · +610298818000
  • Royal Brisbane and Women's Hospital ( Site 0206), Brisbane, Queensland, Australia

    Study coordinator · 0736478111
  • Epworth Freemasons ( Site 0207), Melbourne, Victoria, Australia

    Study coordinator · 0394171344
  • Sir Charles Gairdner Hospital ( Site 0203), Nedlands, Western Australia, Australia

    Study coordinator · +610864573333
  • Medizinische Universität Graz-Abteilung für Gynäkologie / Onkologie ( Site 0303), Graz, Styria, Austria

    Study coordinator · +43316 385 81648
  • Medizinische Universitaet Innsbruck-Univ.-Klinik f. Gynäkologie und Geburtshilfe ( Site 0301), Innsbruck, Tyrol, Austria

    Study coordinator · 435050423051
  • Medizinische Universität Wien - Allg. Gynaekologie & Gyn. Onkologie ( Site 0302), Vienna, Austria

    Study coordinator · +4314040061030
  • CHU Saint-Pierre ( Site 0405), Brussels, Bruxelles-Capitale, Region de, Belgium

    Study coordinator · +3225353534
  • AZ Maria Middelares ( Site 0402), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +3292469522
  • UZ Leuven ( Site 0401), Leuven, Vlaams-Brabant, Belgium

    Study coordinator · +32 16 342 996
  • Grand Hôpital de Charleroi ( Site 0403), Charleroi, Wallonne, Region, Belgium

    Study coordinator · +32 60 11 25 00
  • CHU de Liege ( Site 0404), Liège, Wallonne, Region, Belgium

    Study coordinator · +3243237688
  • Hospital Araújo Jorge ( Site 0521), Goiânia, Goiás, Brazil

    Study coordinator · +55 62 3243-7260
  • Liga Norte Riograndense Contra o Câncer ( Site 0523), Natal, Rio Grande do Norte, Brazil

    Study coordinator · +558440095595
  • Hospital São Lucas da PUCRS ( Site 0522), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133203000
  • IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0525), São Paulo, São Paulo, Brazil

    Study coordinator · +551134744278
  • Instituto Nacional de Câncer - INCA ( Site 0515), Rio de Janeiro, Brazil

    Study coordinator · +552132072985
  • BC Cancer Surrey ( Site 0621), Surrey, British Columbia, Canada

    Study coordinator · 604-930-2098
  • CancerCare Manitoba ( Site 0617), Winnipeg, Manitoba, Canada

    Study coordinator · 204-787-4156
  • NL Health Services ( Site 0602), St. John's, Newfoundland and Labrador, Canada

    Study coordinator · 709-777-6300
  • Royal Victoria Regional Health Centre ( Site 0615), Barrie, Ontario, Canada

    Study coordinator · 705 728-9090x66228
  • London Health Sciences Centre ( Site 0611), London, Ontario, Canada

    Study coordinator · 519-685-8500
  • Sault Area Hospital ( Site 0616), Sault Ste. Marie, Ontario, Canada

    Study coordinator · 705-759-3434x4402
  • Sunnybrook Research Institute ( Site 0610), Toronto, Ontario, Canada

    Study coordinator · 416 480-6100
  • Princess Margaret Cancer Center ( Site 0609), Toronto, Ontario, Canada

    Study coordinator · 416-946-4501
  • Windsor Regional Cancer Program ( Site 0614), Windsor, Ontario, Canada

    Study coordinator · 519-254-5577
  • CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0607), Montreal, Quebec, Canada

    Study coordinator · 514-252-3400 X5766
  • Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0605), Montreal, Quebec, Canada

    Study coordinator · 514-890-8000 x30777
  • Département clinique de médecine de laboratoire du CHUM ( Site 0606), Montreal, Quebec, Canada

    Study coordinator · 514-340-8222
  • McGill University Health Centre ( Site 0604), Montreal, Quebec, Canada

    Study coordinator · 5145772241
  • CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0608), Sherbrooke, Quebec, Canada

    Study coordinator · 8193461110x12890
  • Centro de Estudios Clínicos SAGA ( Site 0708), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56991612199
  • FALP ( Site 0702), Santiago, Region M. de Santiago, Chile

    Study coordinator · +569 97015608
  • Pontificia Universidad Catolica de Chile ( Site 0705), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56942477513
  • Bradfordhill ( Site 0703), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970
  • ONCOCENTRO APYS ( Site 0704), Viña del Mar, Valparaiso, Chile

    Study coordinator · +56323320850
  • Anhui Provincial Hospital ( Site 0830), Hefei, Anhui, China

    Study coordinator · 0551-62283666
  • Peking University Peoples Hospital ( Site 0845), Beijing, Beijing Municipality, China

    Study coordinator · (010) 8832 5988
  • Chongqing University Cancer Hospital ( Site 0838), Chongqing, Chongqing Municipality, China

    Study coordinator · +8602365311341
  • Fujian Province Cancer Hospital ( Site 0802), Fuzhou, Fujian, China

    Study coordinator · 0591-83660063
  • The First Affiliated hospital of Xiamen University ( Site 0822), Xiamen, Fujian, China

    Study coordinator · 0592-2130789
  • Sun Yat-sen University Cancer Center ( Site 0846), Guangzhou, Guangdong, China

    Study coordinator · +86-020-87343272
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University ( Site 0801), Guangzhou, Guangdong, China

    Study coordinator · 020-81332736
  • Zhujiang Hospital of Southern Medical University ( Site 0829), Guangzhou, Guangdong, China

    Study coordinator · +86-020-61643888
  • Cancer Hospital of Shantou University Medical College ( Site 0827), Shantou, Guangdong, China

    Study coordinator · +8675488555844
  • Affiliated Hospital of Guangdong Medical University ( Site 0823), Zhanjiang, Guangdong, China

    Study coordinator · 07592369367
  • Liuzhou People's Hospital ( Site 0831), Liuzhou, Guangxi, China

    Study coordinator · +86772-3612345
  • Guangxi Medical University Affiliated Tumor Hospital. ( Site 0825), Nanning, Guangxi, China

    Study coordinator · +8607715778582
  • Harbin Medical University Cancer Hospital ( Site 0850), Harbin, Heilongjiang, China

    Study coordinator · 0451-86298000
  • Henan Cancer Hospital ( Site 0806), Zhengzhou, Henan, China

    Study coordinator · 0371-65587418
  • The Second Affiliated Hospital of Zhengzhou University ( Site 0833), Zhengzhou, Henan, China

    Study coordinator · 0371-63974853
  • Wuhan Union Hospital Cancer Center ( Site 0824), Wuhan, Hubei, China

    Study coordinator · 027-85726114
  • Xiangya Hospital Central South University ( Site 0821), Changsha, Hunan, China

    Study coordinator · 0731-89753999
  • Hunan Cancer Hospital ( Site 0826), Changsha, Hunan, China

    Study coordinator · 0731-88651900
  • Nanjing First Hospital ( Site 0828), Nanjing, Jiangsu, China

    Study coordinator · 025-52271000
  • Jiangxi Maternal and Child Health Hospital ( Site 0807), Nanchang, Jiangxi, China

    Study coordinator · 0791-82725189
  • The First Hospital Of Jilin University ( Site 0815), Changchun, Jilin, China

    Study coordinator · 0431-88782222
  • The First Affiliated Hospital of Xi'an Jiaotong University ( Site 0816), Xi'an, Shaanxi, China

    Study coordinator · 029-85323840
  • Shandong Cancer Hospital ( Site 0803), Jinan, Shandong, China

    Study coordinator · 0531-87984777
  • LinYi Cancer Hospital ( Site 0820), Linyi, Shandong, China

    Study coordinator · 13583991399
  • Shanghai Tenth People's Hospital ( Site 0847), Shanghai, Shanghai Municipality, China

    Study coordinator · 021-66300588
  • Obstetrics & Gynecology Hospital of Fudan University ( Site 0818), Shanghai, Shanghai Municipality, China

    Study coordinator · 021-33189900
  • Shanxi Provincial Cancer Hospital ( Site 0843), Taiyuan, Shanxi, China

    Study coordinator · (0351) 465 1590
  • West China Second University Hospital, Sichuan University ( Site 0849), Chengdu, Sichuan, China

    Study coordinator · 028-85503776
  • The Second People's Hospital of Yibin ( Site 0840), Yibin, Sichuan, China

    Study coordinator · 0831 888 8120
  • Yunnan Province Cancer Hospital ( Site 0811), Kunming, Yunnan, China

    Study coordinator · 0871-68103376
  • The Affiliated Women's Hospital of Zhejiang University ( Site 0834), Hangzhou, Zhejiang, China

    Study coordinator · 0571-87061501
  • Taizhou Hospital of Zhejiang Province ( Site 0809), Linhai, Zhejiang, China

    Study coordinator · 0576-85199810
  • The First Affiliated Hospital of Wenzhou Medical University ( Site 0805), Wenzhou, Zhejiang, China

    Study coordinator · 0577-55579590
  • Instituto de Cancerología S.A.S ( Site 0904), Medellín, Antioquia, Colombia

    Study coordinator · +57 3007193097
  • Fundacion Colombiana de Cancerología Clinica Vida ( Site 0905), Medellín, Antioquia, Colombia

    Study coordinator · +57 3147362301
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0902), Bogotá, Bogota D.C., Colombia

    Study coordinator · +573183662238
  • Oncologos Del Occidente ( Site 0907), Pereira, Risaralda Department, Colombia

    Study coordinator · +573187715522
  • Fakultni nemocnice Ostrava ( Site 1104), Ostrava, Ostrava Mesto, Czechia

    Study coordinator · +420597371804
  • Nemocnice AGEL Novy Jicin a.s. ( Site 1102), Nový Jičín, Czechia

    Study coordinator · +420556773111
  • Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 1101), Prague, Czechia

    Study coordinator · +420224967451
  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 1103), Prague, Czechia

    Study coordinator · +420224434756
  • Herlev and Gentofte Hospital ( Site 1202), Copenhagen, Capital Region, Denmark

    Study coordinator · +45 38683868
  • Aarhus Universitetshospital, Skejby ( Site 1205), Aarhus, Central Jutland, Denmark

    Study coordinator · +45 78450000
  • Aalborg Universitetshospital, Syd ( Site 1203), Aalborg, North Denmark, Denmark

    Study coordinator · +45 97660000
  • Roskilde Sygehus ( Site 1204), Roskilde, Region Sjælland, Denmark

    Study coordinator · +45 46323200
  • Kuopion Yliopistollinen Sairaala ( Site 1304), Kuopio, Northern Savonia, Finland

    Study coordinator · 358447172741
  • Tampereen yliopistollinen sairaala ( Site 1303), Tampere, Pirkanmaa, Finland

    Study coordinator · 358408484029
  • Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1302), Turku, Southwest Finland, Finland

    Study coordinator · 358405465398
  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1301), Helsinki, Uusimaa, Finland

    Study coordinator · 358504286945
  • Institut Paoli Calmettes ( Site 1410), Marseille, Bouches-du-Rhone, France

    Study coordinator · +33491223847
  • Centre Francois Baclesse ( Site 1412), Caen, Calvados, France

    Study coordinator · +33231455002
  • Hôpital Privé Des Côtes d'Armor ( Site 1404), Plérin, Cotes-d Armor, France

    Study coordinator · +33296752216
  • Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 1405), Bordeaux, Gironde, France

    Study coordinator · +33556333333
  • LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1407), Toulouse, Haute-Garonne, France

    Study coordinator · +33531155101
  • Institut Curie - site Saint-Cloud ( Site 1408), Saint-Cloud, Hauts-de-Seine, France

    Study coordinator · +33147111549
  • Institut De Cancerologie De L Ouest ( Site 1403), Saint-Herblain, Loire-Atlantique, France

    Study coordinator · +33240679900
  • CENTRE LEON BERARD ( Site 1401), Lyon, Rhone, France

    Study coordinator · +33478782716
  • Groupe Hospitalier Diaconesses Croix Saint Simon ( Site 1409), Paris, France

    Study coordinator · +33144741013
  • Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 1411), Paris, France

    Study coordinator · +33158411439
  • Universitaetsklinikum Aachen ( Site 1507), Aachen, North Rhine-Westphalia, Germany

    Study coordinator · +492418080700
  • Klinikum Mutterhaus der Borromäerinnen ( Site 1506), Trier, Rhineland-Palatinate, Germany

    Study coordinator · +4965194782635
  • CaritasKlinikum Saarbruecken St. Theresia ( Site 1508), Saarbrücken, Saarland, Germany

    Study coordinator · +496814061301
  • Universitaetsklinikum Leipzig ( Site 1505), Leipzig, Saxony, Germany

    Study coordinator · +49 341 97 23260
  • Universitaetsklinikum Jena ( Site 1503), Jena, Thuringia, Germany

    Study coordinator · +49 3641 9329155
  • Charité Campus Virchow-Klinikum ( Site 1501), Berlin, Germany

    Study coordinator · +49 30 450 564 404
  • Asklepios Kliniken Hamburg ( Site 1509), Hamburg, Germany

    Study coordinator · +49401818828138
  • Alexandra General Hospital of Athens ( Site 1604), Athens, Attica, Greece

    Study coordinator · 0030 2132162543
  • Aretaieio Hospital ( Site 1602), Athens, Attica, Greece

    Study coordinator · 0030 2107286444
  • ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1603), Chaïdári, Attica, Greece

    Study coordinator · 0030 2313301848
  • Iaso Genera ( Site 1605), Marousi, Attica, Greece

    Study coordinator · 0030 2107286305
  • Agios Loukas Clinic-DEPARTMENT OF ONCOLOGY ( Site 1601), Thessaloniki, Central Macedonia, Greece

    Study coordinator · 0030 2310390972
  • Semmelweis Egyetem Szuleszeti es Nogyogyaszati Klinika ( Site 1703), Budapest, Hungary

    Study coordinator · 06203522207
  • Országos Onkológiai Intézet-Ngyógyászat ( Site 1702), Budapest, Hungary

    Study coordinator · +3612248600 Ext 3616
  • Debreceni Egyetem Klinikai Kozpont-Szülészeti és Nőgyógyászati Klinika ( Site 1701), Debrecen, Hungary

    Study coordinator · 0652255705
  • St. Vincent's University Hospital ( Site 1902), Dublin, Dublin, Ireland

    Study coordinator · +35312214000
  • Cork University Hospital ( Site 1903), Cork, Ireland

    Study coordinator · +353214920500
  • Mater Misericordiae University Hospital ( Site 1904), Dublin, Ireland

    Study coordinator · +35318034831
  • St. James's Hospital ( Site 1901), Dublin, Ireland

    Study coordinator · +35314103752
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 2107), Meldola, Forli-Cesena, Italy

    Study coordinator · +39-0543739968
  • Ospedale Humanitas San Pio X ( Site 2106), Milan, Lombardy, Italy

    Study coordinator · +39-0269517533
  • Ospedale Cannizzaro ( Site 2103), Catania, Italy

    Study coordinator · +39-0957262083
  • Azienda Ospedaliera Universitaria Careggi ( Site 2109), Florence, Italy

    Study coordinator · +39-0557947908
  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 2114), Milan, Italy

    Study coordinator · +39-0223902719
  • Istituto Europeo di Oncologia ( Site 2110), Milan, Italy

    Study coordinator · +39-0294372732
  • Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 2104), Naples, Italy

    Study coordinator · +39-0815903637
  • Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara ( Site 2108), Pisa, Italy

    Study coordinator · +39-050992371
  • Istituto Nazionale Tumori Regina Elena ( Site 2102), Roma, Italy

    Study coordinator · +39-0652666771
  • Fondazione Policlinico Universitario Agostino Gemelli ( Site 2105), Roma, Italy

    Study coordinator · +39-0630154994
  • Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 2111), Torino, Italy

    Study coordinator · +39-0113131523
  • Ospedale Mauriziano ( Site 2101), Torino, Italy

    Study coordinator · +390115082046
  • Ospedale Santa Maria di Ca' Foncello ( Site 2112), Treviso, Italy

    Study coordinator · +39-0422322051
  • Aichi Cancer Center ( Site 2217), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-762-6111
  • National Hospital Organization Shikoku Cancer Center ( Site 2206), Matsuyama, Ehime, Japan

    Study coordinator · +81-89-999-1111
  • Ehime University Hospital ( Site 2213), Tōon, Ehime, Japan

    Study coordinator · +81-89-964-5111
  • Kurume University Hospital ( Site 2204), Kurume, Fukuoka, Japan

    Study coordinator · +81-942-35-3311
  • Gunma Prefectural Cancer Center ( Site 2202), Ōta, Gunma, Japan

    Study coordinator · +81-276-38-0771
  • National Hospital Organization Hokkaido Cancer Center ( Site 2212), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-811-9111
  • Hyogo Cancer Center ( Site 2216), Akashi, Hyōgo, Japan

    Study coordinator · +81-78-929-1151
  • Iwate Medical University Hospital ( Site 2207), Shiwa-gun, Iwate, Japan

    Study coordinator · +81-19-613-7111
  • Saitama Medical University International Medical Center ( Site 2201), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Shizuoka Cancer Center ( Site 2205), Sunto-gun, Shizuoka, Japan

    Study coordinator · +81-55-989-5222
  • National Cancer Center Hospital ( Site 2211), Chūō, Tokyo, Japan

    Study coordinator · +81-3-3542-2511
  • Cancer Institute Hospital of JFCR ( Site 2208), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Keio University Hospital ( Site 2209), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3353-1211
  • National Hospital Organization Kyushu Cancer Center ( Site 2203), Fukuoka, Japan

    Study coordinator · +81-92-541-3231
  • Fukushima Medical University Hospital ( Site 2218), Fukushima, Japan

    Study coordinator · +81-24-547-1772
  • Niigata Cancer Center Hospital ( Site 2210), Niigata, Japan

    Study coordinator · +81-25-266-5111
  • Okayama University Hospital ( Site 2215), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Yamagata University Hospital ( Site 2219), Yamagata, Japan

    Study coordinator · +81-23-628-5840
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 2402), Guadalajara, Jalisco, Mexico

    Study coordinator · +523330447001
  • Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 2401), Monterrey, Nuevo León, Mexico

    Study coordinator · +5283464690
  • Centro de Investigacion Clinica de Oaxaca ( Site 2404), Oaxaca City, Oaxaca, Mexico

    Study coordinator · +529516035559
  • Centro de Investigación Oncológica Galerías SC ( Site 2405), Aguascalientes, Mexico

    Study coordinator · +52 449 689 0593
  • Sitio Clínico UIS Chihuahua (Operadora Unidad de Investigación en Salud de Chihuahua SA de CV) ( Site 2406), Chihuahua City, Mexico

    Study coordinator · +526144372837
  • Maastricht UMC+ ( Site 2501), Maastricht, Limburg, Netherlands

    Study coordinator · +31433876543
  • Universitair Medisch Centrum Utrecht ( Site 2503), Utrecht, Netherlands

    Study coordinator · +31887556263
  • Stavanger Universitetssykehus ( Site 2703), Norway, Rogaland, Norway

    Study coordinator · +4751518000
  • Universitetssykehuset Nord-Norge HF ( Site 2702), Tromsø, Troms, Norway

    Study coordinator · +4777626000
  • Oslo universitetssykehus, Radiumhospitalet ( Site 2701), Oslo, Norway

    Study coordinator · +4722934404
  • Clínica San Felipe ( Site 2804), Jesus Maria, Lima region, Peru

  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 2803), San Isidro, Lima region, Peru

  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 2805), Lima, Peru

    Study coordinator · +5112016500 e3009
  • Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 3011), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48618549014
  • Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie ( Site 3003), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48 61 88 50 738
  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 3004), Siedlce, Masovian Voivodeship, Poland

    Study coordinator · 256403070
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 3002), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · 225462268
  • Bialostockie Centrum Onkologii ( Site 3007), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · 48856646732
  • Uniwersyteckie Centrum Kliniczne-Klinika Ginekologii, Ginekologii Onkologicznej i Endokrynologii Gi ( Site 3001), Gdansk, Pomeranian Voivodeship, Poland

    Study coordinator · +48585844050
  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 3006), Gliwice, Silesian Voivodeship, Poland

    Study coordinator · +48322788613
  • Swietokrzyskie Centrum Onkologii. ( Site 3008), Kielce, Świętokrzyskie Voivodeship, Poland

    Study coordinator · +48885997850
  • Puerto Rico Cancer Specialists Clinical Trials ( Site 4201), San Juan, Puerto Rico

    Study coordinator · +7879452919
  • National University Hospital ( Site 3202), Singapore, Central Singapore, Singapore

    Study coordinator · 67795555
  • National Cancer Centre Singapore ( Site 3201), Singapore, Central Singapore, Singapore

    Study coordinator · +656368000
  • National Cancer Center ( Site 3106), Gyeonggi-do, Kyonggi-do, South Korea

    Study coordinator · +82319202591
  • Keimyung University Dongsan Hospital ( Site 3105), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · +82532586679
  • Seoul National University Hospital ( Site 3102), Seoul, South Korea

    Study coordinator · +82220723511
  • Severance Hospital, Yonsei University Health System ( Site 3101), Seoul, South Korea

    Study coordinator · +82222282250
  • Asan Medical Center ( Site 3103), Seoul, South Korea

    Study coordinator · +82230103748
  • Samsung Medical Center ( Site 3104), Seoul, South Korea

    Study coordinator · +82234101382
  • Institut Català d'Oncologia - L'Hospitalet ( Site 3408), L'Hospitalet de Llobregat, Barcelona, Spain

    Study coordinator · +34932607744
  • Institut Català d'Oncologia (ICO) - Girona ( Site 3407), Girona, Gerona, Spain

    Study coordinator · +34972225834
  • Hospital Universitari Vall d''Hebron ( Site 3401), Barcelona, Spain

    Study coordinator · +34934894350
  • Hospital Universitario Reina Sofia ( Site 3402), Córdoba, Spain

    Study coordinator · +34957011464
  • Hospital Universitario Ramon y Cajal ( Site 3403), Madrid, Spain

    Study coordinator · +34913368263
  • Hospital Universitario 12 de Octubre ( Site 3404), Madrid, Spain

    Study coordinator · +34913908003
  • Hospital Universitario La Paz ( Site 3406), Madrid, Spain

    Study coordinator · +34679927508
  • Fundación Instituto Valenciano de Oncología ( Site 3405), Valencia, Spain

    Study coordinator · +34961114249
  • Skånes Universitetssjukhus Lund ( Site 3502), Lund, Skåne County, Sweden

    Study coordinator · +46171000
  • Akademiska Sjukhuset ( Site 3501), Uppsala, Uppsala County, Sweden

    Study coordinator · 0186110000
  • Taichung Veterans General Hospital ( Site 3703), Taichung, Taiwan

    Study coordinator · 886-4-23592525
  • National Cheng Kung University Hospital ( Site 3702), Tainan, Taiwan

    Study coordinator · +88662353535
  • National Taiwan University Hospital ( Site 3701), Taipei, Taiwan

    Study coordinator · 886-2-23123456
  • Mackay Memorial Hospital ( Site 3704), Taipei, Taiwan

    Study coordinator · +886 975835334
  • Linkou Chang Gung Memorial Hospital ( Site 3705), Taoyuan, Taiwan

    Study coordinator · 886-3-3281200
  • Ramathibodi Hospital. ( Site 3802), Bangkok, Bangkok, Thailand

    Study coordinator · +66822316889
  • Faculty of Medicine Siriraj Hospital ( Site 3801), Bangkok, Bangkok, Thailand

    Study coordinator · +6624141914
  • Maharaj Nakorn Chiang Mai Hospital ( Site 3804), Chiang Mai, Thailand

    Study coordinator · +66804964292
  • Faculty of Medicine - Khon Kaen University ( Site 3803), Khon Kaen, Thailand

    Study coordinator · +6643363029
  • University Hospitals Sussex NHS Foundation Trust ( Site 4011), East Sussex, Brighton And Hove, United Kingdom

    Study coordinator · 01273696955
  • Addenbrookes Hospital ( Site 4002), Cambridge, Cambridgeshire, United Kingdom

    Study coordinator · +441223805000
  • University College London Hospital ( Site 4001), London, London, City of, United Kingdom

    Study coordinator · +442034477807
  • ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 4006), London, London, City of, United Kingdom

    Study coordinator · 02073528171
  • Hammersmith Hospital ( Site 4010), London, London, City of, United Kingdom

    Study coordinator · +443000330333
  • Western General Hospital ( Site 4012), Edinburgh, Midlothian, United Kingdom

    Study coordinator · +441315371000
  • Royal Marsden Hospital (Sutton) ( Site 4005), London, Surrey, United Kingdom

    Study coordinator · 02073528171
  • Leicester Royal Infirmary ( Site 4008), Leicester, United Kingdom

    Study coordinator · +443003031573
  • Maidstone Hospital ( Site 4007), Maidstone, United Kingdom

    Study coordinator · +441622729000
  • The Christie NHS Foundation Trust ( Site 4003), Manchester, United Kingdom

    Study coordinator · +441614463000
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC